Compare MD & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MD | BSTZ |
|---|---|---|
| Founded | 1979 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1996 | N/A |
| Metric | MD | BSTZ |
|---|---|---|
| Price | $20.38 | $21.96 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 771.5K | 207.9K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | ★ 263.03 | N/A |
| EPS | ★ 1.94 | 0.71 |
| Revenue | ★ $1,913,849,000.00 | N/A |
| Revenue This Year | $3.72 | N/A |
| Revenue Next Year | $2.62 | N/A |
| P/E Ratio | ★ $10.21 | $30.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.84 | $15.22 |
| 52 Week High | $24.99 | $23.47 |
| Indicator | MD | BSTZ |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 48.59 |
| Support Level | $16.08 | $20.60 |
| Resistance Level | $21.98 | $22.17 |
| Average True Range (ATR) | 0.70 | 0.43 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 95.15 | 69.06 |
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.